Table 1.
Patients undergoing thumb-sparing surgery | |||||||||||||
Age | Sex | Location | Diagnosis | Presentation | AJCC Stage | Radiotherapy | Chemotherapy | Follow-Up (months) | Local recurrence | Distant metastasis | Status | MSTS score | |
17 | M | Thumb metacarpal | Chondrosarcoma | Primary | II | No | No | 48 | No | No | ned | 29 | |
23 | M | Thenar | Epithelioid sarcoma | Primary | II | Yes | No | 110 | No | No | ned | 30 | |
28 | M | Thumb P1 dorsum | Epithelioid sarcoma | Primary | II | No | No | 58 | No | No | ned | 29 | |
12 | M | Thumb P1 volar | Epithelioid sarcoma | Primary | II | Yes | No | 97 | No | No | ned | 29 | |
13 | M | Thenar | Epithelioid sarcoma | Primary | II | No | No | 64 | no | no | ned | 30 | |
80 | M | 1st web | Synovial sarcoma | Primary | III | Yes | No | 32 | No | No | ned | 27 | |
30 | F | Thenar | Malignant fibrous histiocytoma | Primary | I | No | No | 105 | No | No | ned | 28 | |
31 | F | Thumb P1 dorsum | Malignant fibrous histiocytoma | Primary | II | Yes | No | 5 | No | No | ned | 29 | |
71 | M | 1st web | Myxoid liposarcoma | Primary | III | No | No | 51 | No | Yes | dod | 27 | |
46 | F | Thumb P1 volar | Leiomyosarcoma | Recurrence | I | No | No | 52 | No | No | ned | 28 | |
32 | M | Thenar | Fibrosarcoma | Primary | I | No | No | 78 | No | No | ned | 26 | |
48 | M | Thenar | Myofibroblastic tumor | Primary | I | No | No | 60 | No | No | ned | 29 | |
25 | F | Thumb subungual | Melanoma | Primary | 0 | No | No | 53 | No | No | ned | 29 | |
50 | M | Thumb P1 volar | Squamous cell carcinoma | Primary | 0 | No | No | 35 | No | No | doc | 30 | |
Patients undergoing amputation | |||||||||||||
Age | Sex | Location | Diagnosis | Presentation | Amputation Level | AJCC Stage | Radiotherapy | Chemotherapy | Follow-Up (months) | Local recurrence | Distant metastasis | Status | MSTS score |
56 | F | Thumb P1 volar | Epithelioid sarcoma | Primary | MCPJ | II | No | No | 95 | No | No | ned | 11 |
10 | M | Thumb P1 volar | Synovial sarcoma | Primary | MCPJ | II | No | No | 156 | No | No | ned | 29a |
47 | F | Thenar | Malignant fibrous histiocytoma | Primary | Below elbow | III | No | No | 67 | Yes | No | ned | NAb |
55 | M | Thumb P2 volar | Porocarcinoma | Primary | IPJ | III | No | No | 102 | No | No | ned | 28 |
59 | M | Thumb P2 volar | Squamous cell carcinoma | Primary | IPJ | I | No | No | 52 | No | No | ned | 28 |
63 | M | Thumb subungual | Melanoma | Primary | IPJ | III | No | Yes | 20 | No | Yes | dod | 28 |
73 | F | Thumb subungual | Melanoma | Primary | MCPJ | T4b, c | No | No | 22 | No | Yes | dod | 17 |
50 | F | Thumb subungual | Melanoma | Primary | IPJ | I | No | No | 61 | No | No | ned | 27 |
59 | F | Thumb subungual | Melanoma | Primary | IPJ | I | No | No | 45 | No | No | ned | 27 |
ned no evidence of disease, awd alive with disease, doc died due to other causes, dod died of disease, P1 proximal phalanx, P2 distal phalanx, IPJ interphalangeal joint, MCPJ metacarpophalangeal joint
aPatient underwent staged toe–thumb transfer
bPatient not assessed as she underwent a primary below-elbow amputation and second above-elbow amputation following local tumor recurrence
cPatient refused staging